Injection, How to Breast Cancer Treatment

 

In Indonesia, including Yogyakarta, breast cancer occupies the majority of cases of cancer.

And approximately 20-35 percent of breast cancer in Indonesia with HER2 positive type, so it has a tendency to grow more violent and relatively younger patients (40-50 years).

It was raised from the principal investigator Dr.Johan Sardjito Kurnianda, SpPD-KHOM the launch of Global Security Research  SafeHer Trastuzumab in Hotel Novotel Yogyakarta, Thursday (2/8).

Unlike in most of Europe and America over the process of developing breast cancer and hormonal sufferers are elderly. Type of breast cancer with HER2-positive breast cancer that develops is not through hormonal processes, but because the HER2 protein is produced in excess.

"This type of breast cancer more quickly resistant to standard radiation and chemotherapy drugs," said Johan.

Therefore, to cope with breast cancer with HER2-positive status was given anti-HER2 (Trastuzumab) and the drug has proved effective as monotherapy or in combination with standard chemotherapy. Because it can increase the response to treatment, life expectancy and better quality of life in patients with advanced breast cancer with HER2 positive.

According to Roche Health Medical Management, Dr. Arya Wibitomo, during treatment with Trastuzumab is made through intravenous infusion that takes 30-90 minutes.

Currently, research is being done SafeHer to make innovations in the treatment of HER2 with Trastuzumab positive by injection under the skin (subcutaneous).

'' With the injectable drug delivery is expected to be more comfortable for patients, and safe because it only takes five minutes. Expected later patients could inject themselves like giving insulin to patients with diabetes mellitus,'' said Arya.

SafeHer study was conducted in 40 countries (300 hospitals) with 2,500 patients. In Indonesia, the study was started this year in five hospitals of Education (Dr Dr Sardjito Yogyakarta, Jakarta Ciptomangunkusumo RSUP, Dharmais Cancer Hospital, Jakarta, Bandung and RS Hasan Sadikin Hospital Dr Sutomo Surabaya).